TP53-dependent toxicity of CRISPR/Cas9 cuts is differential across genomic loci and can confound genetic screening

Miguel M. Álvarez‐Álvarez(Institute for Research in Biomedicine), Fran Supek(University of Copenhagen)
Nature Communications
August 4, 2022
Cited by 61


Related Papers